Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
DNA copy number changes in cervical adenocarcinoma
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 56690
Author(s) Dellas, Athanassios; Torhorst, Joachim; Gaudenz, Reto; Mihatsch, Michael J.; Moch, Holger
Author(s) at UniBasel Dellas, Athanassios
Year 2003
Title DNA copy number changes in cervical adenocarcinoma
Journal Clinical cancer research
Volume 9
Number 8
Pages / Article-Number 2985-91
Keywords COMPARATIVE GENOMIC HYBRIDIZATION; SQUAMOUS-CELL CARCINOMA; MOLECULAR-CYTOGENETIC ANALYSIS; UTERINE CERVIX; IN-SITU; CHROMOSOMAL-ABERRATIONS; PROGNOSTIC-SIGNIFICANCE; HUMAN-PAPILLOMAVIRUS; RECURRENT PATTERN; HER-2/NEU GENE
Mesh terms Adenocarcinoma, genetics; Carcinoma, Squamous Cell, genetics; Chromosome Aberrations; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 4; Chromosomes, Human, X; DNA, genetics; DNA, Neoplasm; Female; Gene Amplification; Genes, erbB-2, genetics; Genotype; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lymphatic Metastasis; Nucleic Acid Hybridization; Papillomaviridae, genetics; Phenotype; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms, genetics
Abstract PURPOSE: There is evidence that specific genetic events are involved in the initiation and progression of squamous cell carcinoma of the uterine cervix. The genotype-phenotype correlations in cervical adenocarcinoma (AC) are unclear. Experimental Design: Comparative genomic hybridization was applied to screen for DNA copy number gains and losses in 22 cervical ACs of clinical stage IB. IHC was performed in all of the samples to determine HER-2/neu expression (HercepTest). RESULTS: The most frequent copy number alterations were DNA sequence gains of chromosome 17q (54%). HER-2/neu expression (score 2+) was immunohistochemically detected in 2 of 22 tumors. DNA sequence losses were most prevalent on chromosomes Xq (50%), Xp (36%), 18q (36%), and 4q (36%). DNA sequence losses of chromosome 18q were associated significantly with poor prognosis in cervical AC (P > 0.01). CONCLUSIONS: DNA sequence copy number gains of chromosome 17q are frequent events in ACs of the cervix. However, gains on 17q are not associated with HER-2/neu expression in cervical ACs. The inactivation of tumor suppressor genes on chromosome 18q might be responsible for the progression of both cervical AC and cervical squamous cell carcinoma.
Publisher American Association for Cancer Research
ISSN/ISBN 1078-0432
edoc-URL http://edoc.unibas.ch/dok/A5249147
Full Text on edoc Restricted
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/12912946
ISI-Number WOS:000184680200017
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.379 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/04/2024